[An X-linked lymphoproliferative syndrome (XLP) caused by mutations in the inhibitor-of-apoptosis gene XIAP].
Rigaud
Stéphanie
S
Latour
Sylvain
S
D000361:Agammaglobulinemia / Q000235:genetics; D017209:Apoptosis / Q000502:physiology; D020031:Epstein-Barr Virus Infections / Q000209:etiology / Q000276:immunology; D050172:Genes, X-Linked; D040181:Genetic Diseases, X-Linked / Q000235:genetics*; D020022:Genetic Predisposition to Disease; D006801:Humans; D007694:Killer Cells, Natural / Q000473:pathology; D016131:Lymphocyte Subsets / Q000473:pathology; D051359:Lymphohistiocytosis, Hemophagocytic / Q000235:genetics; D008232:Lymphoproliferative Disorders / Q000235:genetics*; D008297:Male; D008954:Models, Biological; D010641:Phenotype; D017434:Protein Structure, Tertiary; D013163:Splenomegaly / Q000235:genetics; D051636:X-Linked Inhibitor of Apoptosis Protein / Q000737:chemistry / Q000172:deficiency / Q000235:genetics* / Q000502:physiology
D051636:X-Linked Inhibitor of Apoptosis Protein; C496866:XIAP protein, human